Amanote Research
Register
Sign In
A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3
Neurology
- United States
doi 10.1212/wnl.0b013e318257ea5d
Full Text
Open PDF
Abstract
Available in
full text
Categories
Neurology
Date
May 7, 2012
Authors
A. Filla
F. Sacca
G. De Michele
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3
Neurology
Neurology
Spinocerebellar Ataxia Type 3
Axonal Inclusions in Spinocerebellar Ataxia Type 3
Acta Neuropathologica
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Therapeutic Prospects for Spinocerebellar Ataxia Type 2 and 3
Drugs of the Future
Pharmacology
Spinocerebellar Ataxia Type 13
Spinocerebellar Ataxia Type 8
Spinocerebellar Ataxia Type 12
Spinocerebellar Ataxia Type 37
Spinocerebellar Ataxia Type 2